Comparison of 2D and 3D cell cultures of colorectal adenocarcinoma as models for drug screening


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

The cytostatic effects of 5-fluorouracil, oxaliplatin, and 4-(5-methyl-5H-[1,3]dioxolo[4,5-f]-indol-7-yl)-3-(5-fluoro-1-benzofuran-3-yl)-1 H-pyrrole-2,5-dione (9-ING-41), a new glycogen synthase kinase-3 inhibitor, were evaluated in 2D and 3D models of HT-29 colorectal adenocarcinoma cells. The HT-29 cells cultured in 3D were resistant to the test drugs, while in the case of the 2D model, not only cytostatic but also cytotoxic effect was observed. The highest cytotoxic effect was detected upon the addition of 9-ING-41, at high concentrations of which the cell viability decreased to 50% after 3 h of incubation. The results indicate that 3D cultures reproduce the tumor structure and drug resistance more accurately.

About the authors

A. A. Poloznikov

National Medical Research Radiological Center, Ministry of Health of the Russian Federation

Author for correspondence.
Email: andrey.poloznikov@nmicr.ru
Russian Federation, 4 ul. Koroleva, Obninsk, Kaluga Region, 249036

S. V. Nikulin

P. A. Hertsen Moscow Oncology Research Center

Email: andrey.poloznikov@nmicr.ru
Russian Federation, 3 2-i Botkinskii pr-zd, Moscow, 125284

L. V. Bolotina

P. A. Hertsen Moscow Oncology Research Center

Email: andrey.poloznikov@nmicr.ru
Russian Federation, 3 2-i Botkinskii pr-zd, Moscow, 125284

I. N. Gaisina

Department of Medicinal Chemistry and Pharmacognosy, University of Illinois at Chicago

Email: andrey.poloznikov@nmicr.ru
United States, 833 South Wood, Chicago, IL, 60612

B. Ya. Alexeev

National Medical Research Radiological Center, Ministry of Health of the Russian Federation

Email: andrey.poloznikov@nmicr.ru
Russian Federation, 4 ul. Koroleva, Obninsk, Kaluga Region, 249036


Copyright (c) 2019 Springer Science+Business Media, LLC, part of Springer Nature

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies